Skip to main content

Advertisement

Table 3 Correlation between BMD and serum cytokines, and biochemical markers in children with chronic hepatitis C treated with IFN-alpha.

From: Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

IL-1β .501**             
IL-2r .075 .096            
IL-6 .167 -.101 -.163           
IL-8 .137 .251 .248 -.126          
PTH .005 -.012 .009 .121 .088         
s-CTX -.087 -.253 .140 -.060 .372** -.155        
ALP -.013 -.049 -.055 -.092 .361** -.102 .179       
Osteocalcin .105 -.355** .016 .135 -.205 -.101 .256 -.006      
ALT .189 .494** .087 -.161 .243 .122 -.257 .251 -.206     
AST .214 .528** .125 -.192 .253 .089 -.222 .252 -.155 .960**    
L 2–4 BMD -.159 .019 -.330* .036 .138 .226 .122 .072 -.118 .122 .084   
Femur Neck BMD -.112 -.043 -.246 .025 .105 .179 .067 .303* -.034 .163 .097 .704**  
Trochanter BMD -.111 -.039 -.237 -.006 .123 .090 .017 .365** -.125 .198 .125 .697** .943**
  TNF-α IL-1β IL-2r IL-6 IL-8 PTH s-CTX ALP Osteocalcin ALT AST L 2–4 BMD Femur Neck BMD
  1. ** Correlation is sigificant at the 0.01 level (2-tailed).
  2. * Correlation is significant at the 0.05 level (2-tailed).